Comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 vs 3q27 3 Microdeletion Syndrome C4749427
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Isolated 17 20 Lyase Deficiency and 3q27 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
A rare condition involving deficiency of the 17,20-lyase enzyme needed for androgen synthesis. Affects 46,XY individuals and causes undervirilization. Managed with hormone therapy.
3q27 3 Microdeletion Syndrome C4749427
A rare chromosomal condition where a small piece of chromosome 3 is missing. It can affect physical development, growth, and learning. Management involves specialized care to address specific symptoms.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
0-0
3q27 3 Microdeletion Syndrome C4749427
0-0
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
severe
3q27 3 Microdeletion Syndrome C4749427
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
Chronic
3q27 3 Microdeletion Syndrome C4749427
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
No
3q27 3 Microdeletion Syndrome C4749427
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
reproductive
3q27 3 Microdeletion Syndrome C4749427
congenital
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
endocrine
3q27 3 Microdeletion Syndrome C4749427
genetic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-isolated-17-20-lyase-deficiency-C5681470 and 3q27-3-microdeletion-syndrome-C4749427 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 3q27 3 Microdeletion Syndrome C4749427 | Discriminating power |
|---|---|---|---|
| Main clinical domain | Undervirilization linked to impaired androgen synthesis. | Variable effects on physical development, growth, and learning. | High |
| Cause | Isolated 17,20-lyase deficiency, an endocrine disorder. | Small missing segment of chromosome 3, a genetic condition. | High |
| Reported severity | Classified as severe and mainly reproductive. | Classified as moderate and congenital or developmental. | Moderate |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 when
46,XY person with undervirilization
This matches the described androgen-synthesis problem better than a chromosomal syndrome.
Moderate
Specialist endocrine testing suggests isolated lyase impairment
A confirmed hormone pattern would support the left condition, but cutoffs are not supplied.
Moderate
No broader developmental syndrome is evident
The left condition is defined by sex development rather than learning or growth effects.
Low
Choose 3q27 3 Microdeletion Syndrome C4749427 when
Growth, physical development, or learning concerns predominate
These features align more closely with the described microdeletion.
Moderate
Chromosomal testing identifies a 3q27.3 deletion
This finding supports the right diagnosis when interpreted by a genetics clinician.
High
Features extend beyond reproductive development
The right condition is a congenital chromosomal disorder with variable effects.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 3q27 3 Microdeletion Syndrome C4749427 | Interpretation |
|---|---|---|---|
| Androgen and steroid pathway tests | May indicate impaired androgen synthesis; exact values are not established here. | Not expected to establish the microdeletion. | An abnormal hormone result requires specialist interpretation and is not itself a diagnosis. |
| Karyotype | 46,XY by definition, without proving the enzyme deficiency. | Usually does not identify a small 3q27.3 deletion. | Karyotype provides context but cannot alone distinguish either condition. |
| Chromosomal microarray | No 3q27.3 deletion is expected in an isolated enzyme deficiency. | May detect the missing chromosomal segment. | Genetic confirmation needs clinical correlation; a laboratory finding is not the complete diagnosis. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
- Outcome
- Chronic endocrine condition; long-term outcome is not established from the supplied data.
- Factors
- Degree of undervirilization, hormone findings, and specialist management.
3q27 3 Microdeletion Syndrome C4749427
- Outcome
- Chronic developmental condition with variable impact; prognosis is not established here.
- Factors
- Genetic findings, growth, learning needs, and available supports.
Time frame: Lifelong follow-up is typical, but specific timelines are not established.
Early specialist assessment may guide care, although outcomes cannot be predicted from these data.
Complications comparison
| Complication | Presentation |
|---|---|
| Sex development and fertility | Undervirilization and possible reproductive effects; specifics are not established. Not described as a defining feature. Do not assume particular anatomy, fertility, or complications. |
| Growth and learning | Not described as primary features. Growth and learning may be affected to a variable extent. Individual developmental assessment is needed. |
| Long-term care needs | Chronic endocrine follow-up and hormone therapy may be used; doses are not specified. Specialized multidisciplinary care addresses individual symptoms. Complication rates and outcomes are not established in the source. |
Patient education highlights
- HighDifferent rare conditions
One affects androgen production in 46,XY individuals; the other is a small missing piece of chromosome 3.
- HighTests need interpretation
An abnormal hormone or genetic result is not automatically a diagnosis and should be reviewed by specialists.
- MediumIndividualized care
Management may include hormone therapy or developmental support, but exact treatment and outcomes are not established here.